130 related articles for article (PubMed ID: 38773660)
1. Applying dynamic contrast-enhanced MRI tracer kinetic models to differentiate benign and malignant soft tissue tumors.
Gao A; Wang H; Zhang X; Wang T; Chen L; Hao J; Zhou R; Yang Z; Yue B; Hao D
Cancer Imaging; 2024 May; 24(1):64. PubMed ID: 38773660
[TBL] [Abstract][Full Text] [Related]
2. Discrimination between benign and malignant breast lesions using volumetric quantitative dynamic contrast-enhanced MR imaging.
Cheng Z; Wu Z; Shi G; Yi Z; Xie M; Zeng W; Song C; Zheng C; Shen J
Eur Radiol; 2018 Mar; 28(3):982-991. PubMed ID: 28929243
[TBL] [Abstract][Full Text] [Related]
3. High-temporal resolution DCE-MRI improves assessment of intra- and peri-breast lesions categorized as BI-RADS 4.
Liu Y; Wang S; Qu J; Tang R; Wang C; Xiao F; Pang P; Sun Z; Xu M; Li J
BMC Med Imaging; 2023 Apr; 23(1):58. PubMed ID: 37076817
[TBL] [Abstract][Full Text] [Related]
4. Benign or Malignant Characterization of Soft-Tissue Tumors by Using Semiquantitative and Quantitative Parameters of Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
Zhang Y; Yue B; Zhao X; Chen H; Sun L; Zhang X; Hao D
Can Assoc Radiol J; 2020 Feb; 71(1):92-99. PubMed ID: 32062994
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of diffusion-weighted (DWI) and dynamic contrast-enhanced (DCE) MRI for the differentiation of benign from malignant soft-tissue tumors.
Choi YJ; Lee IS; Song YS; Kim JI; Choi KU; Song JW
J Magn Reson Imaging; 2019 Sep; 50(3):798-809. PubMed ID: 30663160
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric quantitative analysis of tumor perfusion and diffusion with 3T MRI: differentiation between benign and malignant soft tissue tumors.
Lee SK; Jee WH; Jung CK; Chung YG
Br J Radiol; 2020 Nov; 93(1115):20191035. PubMed ID: 32649224
[TBL] [Abstract][Full Text] [Related]
7. On the potential use of dynamic contrast-enhanced (DCE) MRI parameters as radiomic features of cervical cancer.
Lu Y; Peng W; Song J; Chen T; Wang X; Hou Z; Yan Z; Koh TS
Med Phys; 2019 Nov; 46(11):5098-5109. PubMed ID: 31523829
[TBL] [Abstract][Full Text] [Related]
8. Clinical Applications of DSC-MRI Parameters Assess Angiogenesis and Differentiate Malignant From Benign Soft Tissue Tumors in Limbs.
Bian Y; Jin P; Wang Y; Wei X; Qiang Y; Niu G; Jin G; Yang J
Acad Radiol; 2020 Mar; 27(3):354-360. PubMed ID: 31151900
[TBL] [Abstract][Full Text] [Related]
9. Application of Distributed Parameter Model to Assessment of Glioma IDH Mutation Status by Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
Li Z; Zhao W; He B; Koh TS; Li Y; Zeng Y; Zhang Z; Zhang J; Hou Z
Contrast Media Mol Imaging; 2020; 2020():8843084. PubMed ID: 33299387
[TBL] [Abstract][Full Text] [Related]
10. Assessment of quantitative dynamic contrast-enhanced MRI in distinguishing different histologic grades of breast phyllode tumor.
Yi Z; Xie M; Shi G; Cheng Z; Zeng H; Jiang N; Wu Z
Eur Radiol; 2022 Mar; 32(3):1601-1610. PubMed ID: 34491383
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of Benign from Malignant Adnexal Masses by Dynamic Contrast-Enhanced MRI (DCE-MRI): Quantitative and Semi-quantitative analysis at 3-Tesla MRI.
Gity M; Parviz S; Saligheh Rad H; Fathi Kazerooni A; Shirali E; Shakiba M; Baikpour M
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1073-1079. PubMed ID: 31030476
[TBL] [Abstract][Full Text] [Related]
12. Quantitative dynamic contrast-enhanced MR imaging for differentiating benign, borderline, and malignant ovarian tumors.
Li HM; Feng F; Qiang JW; Zhang GF; Zhao SH; Ma FH; Li YA; Gu WY
Abdom Radiol (NY); 2018 Nov; 43(11):3132-3141. PubMed ID: 29556691
[TBL] [Abstract][Full Text] [Related]
13. Dual-input tracer kinetic modeling of dynamic contrast-enhanced MRI in thoracic malignancies.
Lee SH; Rimner A; Deasy JO; Hunt MA; Tyagi N
J Appl Clin Med Phys; 2019 Nov; 20(11):169-188. PubMed ID: 31602789
[TBL] [Abstract][Full Text] [Related]
14. Assessment of dynamic contrast-enhanced magnetic resonance imaging in the differentiation of pancreatic ductal adenocarcinoma from other pancreatic solid lesions.
Liu K; Xie P; Peng W; Zhou Z
J Comput Assist Tomogr; 2014; 38(5):681-6. PubMed ID: 24943251
[TBL] [Abstract][Full Text] [Related]
15. Combined diffusion-weighted imaging and dynamic contrast-enhanced MRI for differentiating radiologically indeterminate malignant from benign orbital masses.
Xu XQ; Qian W; Ma G; Hu H; Su GY; Liu H; Shi HB; Wu FY
Clin Radiol; 2017 Oct; 72(10):903.e9-903.e15. PubMed ID: 28501096
[TBL] [Abstract][Full Text] [Related]
16. Multiparametric approach with diffusion-weighted imaging and dynamic contrast-enhanced MRI: a comparison study for differentiating between benign and malignant bone lesions in adults.
Oh E; Yoon YC; Kim JH; Kim K
Clin Radiol; 2017 Jul; 72(7):552-559. PubMed ID: 28325514
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Volumetric Perfusion Quantitative Parameters Using CS-VIBE Breast Dynamic Contrast Enhanced MR Imaging.
Chang YW; Lee EJ; Hwang J; Nickel D; Sung JK
Curr Med Imaging; 2023; 19(11):1286-1294. PubMed ID: 36165524
[TBL] [Abstract][Full Text] [Related]
18. Texture analysis of magnetic resonance image to differentiate benign from malignant myxoid soft tissue tumors: A retrospective comparative study.
Chang H; Kang Y; Ahn JM; Lee E; Lee JW; Kang HS
PLoS One; 2022; 17(5):e0267569. PubMed ID: 35587928
[TBL] [Abstract][Full Text] [Related]
19. Separation of benign and malignant breast lesions using dynamic contrast enhanced MRI in a biopsy cohort.
Kim SG; Freed M; Leite APK; Zhang J; Seuss C; Moy L
J Magn Reson Imaging; 2017 May; 45(5):1385-1393. PubMed ID: 27766710
[TBL] [Abstract][Full Text] [Related]
20. Dynamic contrast-enhanced MRI in orbital lymphoproliferative disorders: Effects of region of interest selection methods on time efficiency, measurement reproducibility, and diagnostic ability.
Qian W; Xu XQ; Hu H; Su GY; Wu JF; Shi HB; Wu FY
J Magn Reson Imaging; 2018 May; 47(5):1298-1305. PubMed ID: 28922524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
